HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clairol Hair-Dye Suit Cites PPD Use, ‘Inadequate’ Home Sensitization Test

This article was originally published in The Rose Sheet

Executive Summary

Current and former owners Coty and P&G knew or should have known about product hazards associated with Clairol Balsam Color hair-dye kits that are not adequately communicated to consumers, including the sensitizing potential of p-phenylenediamine, according to a putative class action filed in Alabama district court.

You may also be interested in...



Cosmetic Talc Under Scrutiny As Liability Buzzards Circle

Plaintiff’s attorneys are tracking reports of asbestos-contaminated cosmetics at specialty retail stores, signaling a possible new wave of talc-related litigation to come. The issue also has the attention of NGOs, legislators and FDA.

FDA Eyeing Study On Cosmetic Hair-Care/Hair-Loss Link

Interested parties capable of conducting in vivo and in vitro tests "to study alopecia that may be associated with the use of commercially available cosmetic hair products and individual ingredients in these products" must respond to FDA's Sources Sought Notice by Feb. 26.

2017 In Review: Plaintiffs Find New Angles For Attacking Cosmetics' Authenticity

Rose Sheet's coverage of consumer litigation targeting personal-care companies for deceptive claims, among other alleged violations, yielded some of its most-read stories in 2017, based on online analytics. Trends are likely to carry over and, in some cases, pick up steam in 2018.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS109068

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel